Improve Cell Viability

After three days in the cold, do your cells look like those on the left or those stored in HypoThermosol?

Try BioLife

Interested in evaluating our products? Enter your email address and click "Get a Vial."

CryoStor cryopreservation
freeze media

HypoThermosol hypothermic storage media

Improve Cell Viability

Finally! You can eliminate serum from your freeze media. Discover CryoStor.

Home

Print Friendly
BioLife Solutions manufactures and markets proprietary protein-free, serum-free cGMP biopreservation media for cells, tissues, and organs. We perform contract R & D and offer biopreservation protocol consulting. And for select customers, we perform custom formulation, fill, and finish services. NEW! Single-Use Syringes and Bulk Dispensing Bags.

Products

CryoStor®
Pre-formulated with 2, 5, 10%, or a custom volume of USP-grade DMSO, CryoStor yields superior post-thaw cell viability, recovery, and function. Serum-free and protein-free!

HypoThermosol®
Protein-free, serum-free hypothermic storage media are designed for maximum shelf life and shipping stability at 2-8°C.

BloodStor®
cGMP cryopreservation media for freezing stem cells isolated from umbilical cord blood, peripheral blood, and bone marrow. Formulated with 55% USP-grade DMSO, 5% USP-grade Dextran, and WFI-quality water.

Biolife CryoQ productCryoQ™
Designed for shipment of small volumes of bio-materials which need to be shipped with dry ice at extremely stable deep-frozen temperatures.

BioLife PHD productPHD™
Designed for the shipment of materials, which must be maintained at 2-8˚C. Ideal for small volume shipments from single dose to 3L in volume. Antifreeze technology eliminates risk of freezing out of 2-8˚C range during shipping.

Services

Contract Research
Leverage our expertise to optimize your biopreservation protocols.

Formulation, Fill, and Finish
Outsource your biopreservation media manufacturing to BioLife.

Distributors

Distribution Partners

Evidence

CryoStor versus Alternative Cryopreservation Media

HypoThermosol versus Alternative Hypothermic Storage

BioPreservation Today® Archives

BPT-Fall_2013 vF3C (2)web

Latest News

BioLife Solutions Reports Preliminary Revenue for 2014 Press Release>>

BioLife Solutions Biopreservation Media Products Embedded in 175 Cellular Immunotherapy & Other Regenerative Medicine Clinical Trials Press Release>>

BioLife Solutions Sets Date for Annual Meeting of Stockholders Press Release>>

BioLife Solutions Sets Date for Annual Meeting of Stockholders Press Release>>

BioLife Solutions Names Pharmaceutical Industry Expert Kevin O’Donnell as Vice President, Cold Chain Standards, Practices & Compliance Press Release>>

BioLife Solutions to Present at the LD Micro “Main Event” Investor Conference on Wednesday, December 3, 2014
Press Release>>

See all news >>

Events

ECI Scale-Up and Manufacturing of Cell-Based Therapies IV
January 18-22, 2015

Phacilitate’s Cell & Gene Forum 2015
January 26-28, 2015

See all events >>

 Fast500

Connect with BioLife